Publication

Development of cyclic peptide inhibitors of coagulation factor XII and matrix metalloproteinase 2

Related publications (77)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Development of cyclic peptide inhibitors of coagulation factor XII and matrix metalloproteinase 2

Graph Chatbot

Chat with Graph Search

Aptamer-Functionalized Interface Nanopores Enable Amino Acid-Specific Peptide Detection

Solid-phase peptide synthesis in 384-well plates

Interrupted Polonovski Strategy for the Synthesis of Functionalized Amino Acids and Peptides

Synthesis and application of bifunctional hypervalent iodine reagents for peptide modification.

High-affinity peptides developed against calprotectin and their application as synthetic ligands in diagnostic assays

Synthesis of Trifluoromethylated Alkenes: Hypervalent Iodine Meets High-Valent Copper

Development of cyclic peptides that can be administered orally to inhibit disease targets

De novo developed small cyclic peptides that are orally available

Cyclative Release Strategy to Obtain Pure Cyclic Peptides Directly from the Solid Phase